Forbes Article Explores AI's Inflection Point in Pharma and Compliance

A Forbes article discusses the critical inflection point for AI in the pharmaceutical industry, highlighting five key lessons for Chief AI Officers, particularly emphasizing the non-negotiable aspect of compliance in regulated environments.